ProCE Banner Activity

Integration of Palliative and Oncology Care for Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes Treated With Nonintensive Therapy

Conference Coverage
Slideset

For patients with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS) receiving nonintensive therapy, an integrated palliative care intervention improved quality of life, discussion of end of life (EOL) care, and resulted in earlier documentation of EOL preferences.

Released: June 04, 2024

Expiration: June 03, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from GSK, Lilly, Novartis Pharmaceuticals Corporation, and Sanofi.

GSK

Lilly

Novartis Pharmaceuticals Corporation

Sanofi